Obesity-induced hypothalamic inflammation is closely associated with various metabolic complications and neurodegenerative disorders. Astrocytes, the most abundant glial cells in the central nervous system, play a crucial role in pathological hypothalamic inflammatory processes. Here, we demonstrate that hypothalamic astrocytes accumulate lipid droplets under saturated fatty acid-rich conditions, such as obese environment, and that the lipid-laden astrocytes increase astrogliosis markers and inflammatory cytokines (TNFa, IL-1b, IL-6, MCP-1) at the transcript and/or protein level. Medium conditioned by the lipid-laden astrocytes stimulate microglial chemotactic activity and upregulate transcripts of the microglia activation marker Iba-1 and inflammatory cytokines. These findings indicate that the lipid-laden astrocytes formed in free fatty acid-rich obese condition may participate in obesityinduced hypothalamic inflammation through promoting microglia migration and activation.
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hypothalamus is an important region that regulates food intake, sleep, thermoregulation, and energy homeostasis. There is accumulating evidence that obesity induces low-grade inflammation in the hypothalamus, leading to the dysregulation of energy homeostasis, leptin/insulin resistance, and neurodegenerative disease, as well as cognitive deficit [11] [12] [13] [14] . Hence, understanding hypothalamic inflammation is important to protect against obesity-related metabolic complications and neuropathological processes.
The hypothalamus contains a heterogeneous population of cells composed of neurons and non-neuronal glial cells such as astrocytes, microglia, and oligodendrocytes, which together outnumber the neurons by 10 : 1 [15] . Astrocytes comprise the largest portion of the glial cells, and are considered to be the first line in responses to fluctuations in systemic and local levels of nutrients and other mediators [16] . Accordingly, astrocytes act as metabolic sensors to provide a nurturing environment for regulation of neuronal function (e.g., survival, synaptic plasticity, development, metabolism, and neurotransmission). Various inflammatory stimuli increase astrocytes reactivity, which is characterized by morphological change and upregulation of the intermediate filament glial fibrillary acidic protein (GFAP) accompanied by activation of a transcriptional program involved in the inflammatory pathway [17] . On the other hand, microglial cells, the resident macrophages, are responsible for surveillance of the central nervous system. Microglial cells are relatively quiescent, but they respond to inflammatory stimuli by phagocytosing bacteria or cellular debris, as well as by secreting various inflammatory mediators [18, 19] . Acute and/or chronic inflammatory activations of astrocytes and microglia result in neuronal injury and are therefore crucial for metabolic dysregulation and neurodegeneration [17, 20] , suggesting that these glial cells may be valid targets to control hypothalamic inflammation.
Of note, the hypothalamus has a unique vascular system in terms of fenestrated capillaries in the median eminence, which are lack of a normal blood brain barrier (BBB), and BBB permeability increases under HFDfeeding/obese conditions, allowing astrocytes to directly respond to peripheral excess nutrient signals such as fatty acids [21] . Studies have shown that both astrocytes and microglia can directly sense FFA through the expression of toll-like receptors (TLRs) such as TLR4, indicating that hypothalamic glial cells may play a crucial role in HFD/obesity-induced hypothalamic inflammation [12, 22] . However, the exact role of these glial cells in the onset and/or progress of the obesity-induced hypothalamic inflammation remain unclear. In this study, we demonstrate that hypothalamic astrocytes (H-astrocytes) accumulate lipid droplets under fatty acidrich environments such as obese/diabetic conditions, and that lipid-laden astrocytes-derived inflammatory mediators induce microglia migration and activation, augmenting hypothalamic inflammatory responses. These findings suggest that lipid-laden astrocytes and their crosstalk with microglia may be crucial for obesity-induced hypothalamic inflammation. per well) in 12-well plates were treated with lipid-laden astrocytes-conditioned medium (LL-As-CM) for 4 h. To prepare the LL-As-CM, primary astrocytes were treated with LL-As-CM or without palmitate [Control astrocytes-conditioned medium (C-As-CM)] for 48 h, then cultured for 24 h without palmitate, before the media were collected.
Materials and methods

Cell culture
Isolation of astrocytes
Primary astrocytes cultures were prepared form whole brain astrocytes (W-astrocytes) and/or H-astrocytes of newborn (postnatal day 1-2 day) C57BL/6 mice [24] . Briefly, the whole brain or hypothalamus were dissociated and grinded in the plate involving DMEM high glucose (25 mM; Gibco) supplemented with 10% FBS (Gibco). Dissociated cells were collected by centrifugation at 200 g for 3 min and seeded on in 75 cm 2 tissue culture flasks and grown at 37°C in a 5% CO 2 incubator. Cultures were continued for a week with a change in medium thrice a week. Pure astrocytes cultures were obtained by shaking mixed glial cultures at 240 r.p.m. overnight, and then culture media were discarded. Astrocytes were dissociated using trypsin-EDTA (Gibco) and then collected by centrifugation at 200 g for 3 min. Purity of the cells, as determined by GFAP immunostaining using flow cytometry, was > 94-97% (data not shown). Primary astrocytes (4 9 10 5 cells per well) in 12-well plates, was treated with palmitate for 48 h or 6 h, respectively.
Oil-red O staining and triglyceride measurement
Astrocytes-containing lipid droplets were stained with Oilred O. Adherent cells were washed with PBS and fixed in 10% formalin for 10 min, then rinsed with 60% isopropanol and stained with Oil-red O working solution.
After washing three times with distilled water, the stained cells were photographed with a microscope (Olympus, Japan). Astrocytes were cultured with palmitate (200 lM) in each well of a 12-well plate for 48 h, after which they were harvested and lysed via freeze-thaw in 50 lL PBS. The triglyceride contents of the cell lysates were analyzed using a triglyceride assay kit (Asan Pharm. Co., Seoul, Korea) according to the manufacturer's instructions. The cellular protein concentration was determined using a bicinchoninic acid protein assay kit. Cellular triglyceride content was normalized to the cellular protein content.
Measurement of inflammatory cytokines
Cytokine levels in culture supernatants were measured using enzyme-linked immunosorbent assays (ELISA). The assays were conducted using a mouse MCP-1 set (BD Bioscience Pharmingen, San Diego, CA, USA) and a mouse IL-6 set (R&D Systems, Minneapolis, MN, USA). Values for cytokine levels were derived from standard curves using the curve-fitting program SOFTMAX (Molecular Devices, Sunnyvale, CA, USA).
RT-PCR
Total RNA extracted from cultured cells or hypothalamuses was reverse transcribed to generate cDNA using M-MLV reverse transcriptase (Promega, Madison, WI, USA). Realtime PCR amplification of the cDNA was conducted with a SYBR premix Ex Taq kit (TaKaRa Bio Inc., Foster, CA, USA) using a Thermal Cycler Dice (TaKaRa Bio Inc., Shiga, Japan). All reactions were performed by subjecting the samples to the following conditions: initial denaturation at 95°C for 10 s, followed by 40 cycles of 95°C for 5 s and 60°C for 30 s. All values for genes of interest were normalized to those of the housekeeping gene, b-actin. Data were analyzed using the Thermal Cycler Dice Real Time System Software (Takara Bio, Inc. 
Chemotaxis of microglia
Chemotaxis of the microglia cells was assayed with a 96-well disposable chemotaxis system and 5-lm polycarbonate filters (Chemotaxis; Neuroprobe, Gaithersburg, MD, USA). Briefly, 27 lL of lipid-laden astrocytes-conditioned medium was added to the bottom chamber of the chemotaxis plate, and 5 9 10 4 cell of microglia cells was added to the top of the chamber. The plate was then incubated at 37°C in 5% CO 2 for 4 h. To quantify the number of cells that migrated through the filter, nonmigrating cells on the upper side of the filter were removed by gentle scraping. The filter was then dried and stained with Hemacolor 1, Hemacolor 2, and Hemacolor 3 (Microscopy, Merck KGaA, Darmstadt, Germany) for 3 min each. After washing three times with distilled water, the filter was dried for 5 min. To fix the filter, filters were mounted on glass slides overnight at room temperature. Microglia migration was visualized by counting the number of microglia.
Statistical analysis
The results are presented as means AE SEM. Statistical analyses were performed using Student's t-test. Differences were considered significant at P < 0.05.
Results
Increased reactivity of astrocytes by obese ATCM and obesity-related factors
To determine if obesity-related peripheral factors increase astrocytes reactivity, we treated astrocytes with ATCM, TNFa, and LPS. Astrocytes were cultured in DMEM containing high glucose (25 mM), mimicking hyperglycemia, which is a pathophysiological condition relevant to obese/diabetes [25, 26] . The ATCM was prepared by culturing adipose tissue isolated from obese mice fed an HFD or lean mice fed a regular diet (control). As shown in Fig. 1 , ATCM treatment in astrocytes markedly upregulated reactive astrocytes markers such as GFAP and vimentin (Fig. 1A) . Moreover, astrocytes treated with ATCM released large amounts of inflammatory cytokines and chemokines such as IL-6 and MCP-1 (Fig. 1B) . We next examined the effects of TNFa, which are released from adipose tissue under obese conditions, on astrocytes reactivity. Treatment of TNFa significantly increased production of the inflammatory mediators (Fig. 1C) . Additionally, treatment of FFA (palmitate) for 6 h significantly upregulated the transcript levels of inflammatory cytokine genes such as TNFa, IL-1b, IL-6, and MCP-1 from astrocytes isolated from the postnatal whole brain and/or hypothalamus (Fig. 1D) . These indicate that astrocytes could release inflammatory cytokines under obese condition. However, a small portion of microglia contamination in the primary astrocytes culture influences the inflammatory response (nitric oxide, reactive oxygen species, cytokine release) of astrocytes [27, 28] , and thus we cannot rule out the involvement of microglia in the inflammatory response of astrocytes observed in this study.
Accumulation of lipid droplets in astrocytes by exposure to palmitate
Astrocytes are metabolically active cells that are considered to be the first line responding to systemic and local levels of nutrients. In this study, we examined whether astrocytes have the potential to accumulate lipid droplets in FFA-rich condition, mimicking an obese environment. We treated astrocytes with 200 lM of saturated fatty acid (palmitate) for 48 h. Microscopic observation and Oil-red O staining showed that astrocytes (C8-D1A, primary astrocytes isolated from postnatal whole brain and/or hypothalamus) accumulated lipid droplets ( Fig. 2A,B) . Biochemical measurement confirmed the increase in triglyceride content in the lipid-laden astrocytes treated with palmitate (Fig. 2C) . We also observed that the transcript levels of genes such as ACSL1 and/or perilipin 1 and 2 ( Fig. 2D) , which are involved in the formation of lipid droplets biogenesis, were significantly upregulated in the lipid-laden astrocytes.
Inflammatory responses in lipid-laden astrocytes
We next examined whether lipid-laden astrocytes elicit the inflammatory phenotype. To accomplish this, we prepared lipid-laden astrocytes treated with FFA for 48 h and nontreated astrocytes (control), then collected the cells and/or conditioned medium (24 h) and measured the levels of inflammatory cytokines by RT-PCR and/or ELISA. As shown in Fig. 3 , transcript levels of inflammatory cytokine genes (TNFa, IL-1b, IL-6, and MCP-1) and protein release (MCP-1, IL-6) markedly increased in the lipid-laden astrocytes (primary astrocytes isolated from postnatal whole brain and/or hypothalamus) compared with the nontreated control.
Chemotactic activity of microglia and microglia activation treated with lipid-laden astrocytesconditioned medium
To determine if the LL-As-CM increases the chemotactic activity of microglia, we treated microglia with the LL-As-CM or control (C-As-CM), then measured their chemotactic activity. As shown in Fig. 4A , LL-As-CM significantly enhanced microglia migration compared with the control. We also found that the expression of CCR2 (C-C chemokine receptor 2), which is the receptor for MCP-1, was upregulated in the LL-As-CM treated microglia (Fig. 4C) . Moreover, the LL-As-CM-induced chemotactic activity of the microglia was blunted by treatment with the anti-MCP-1 antibody (Fig. 4B) . We next examined whether LL-As-CM can cause microglia activation. To accomplish this, we treated microglia with LL-As-CM and measured inflammatory cytokine production. In comparison with control (C-As-CM), LL-As-CM obtained from primary astrocytes significantly upregulated the transcript levels of inflammatory cytokines (TNFa, IL1b, IL-6, and MCP-1) in microglia (Fig. 4D) , and increased the MCP-1 released from the microglia (Fig. 4E) . We also confirmed that LL-As-CM treatment upregulated Iba1 and CD11b, a marker for microglia activation (Fig. 4F) . 
Discussion
Obesity-induced peripheral inflammation is associated with hypothalamic inflammation; however, the peripheral factors promoting the central inflammation and the cellular mechanisms are not fully understood. In this study, using primary astrocytes from whole brain and/or hypothalamus, we demonstrated for the first time that treatment of astrocytes with obese ATCM markedly increased inflammatory cytokine genes/proteins such as MCP-1, IL-6, IL-1b, and TNFa, and that it also upregulated the transcription of reactive astrogliosis markers such as GFAP and vimentin, indicating that adipose tissue-derived peripheral factors in obese conditions may increase the inflammatory reactivity of H-astrocytes. Of note, circulating mediators such as FFA and TNFa are known to penetrate the leaky BBB and promote hypothalamic inflammation [29, 30] , leading to neuronal injury and dysfunction [31] . The effects of saturated fatty acid palmitate on inflammatory signaling through TLR4 pathways have been reported in cultured rat astrocytes [32] . Thus, it is conceivable that increased influx of FFA and/or TNFa into the hypothalamus, derived from obese adipose tissues or an HFD rich in palmitate increases inflammatory reactivity of astrocytes. Indeed, we observed that the treatment of FFA or TNFa markedly upregulated the transcript and protein levels of the inflammatory cytokines (MCP-1, IL-6, IL-1b, or TNFa) in astrocytes. Given that astrocytes are the first line to detect peripheral factors that cross the leaky BBB, our findings suggest that the increased penetration of adipose tissue-derived peripheral factors such as FFA and/or TNFa may increase the reactivity of astrocytes accompanied by upregulation of inflammatory genes/proteins in obese condition.
The most intriguing finding in this study is that astrocytes elicit inflammatory reactivity when the cells accumulate lipid droplets under FFA-rich conditions (Fig. 5) . Continuous exposure to sustained elevation of circulating FFA in obese and diabetic conditions cause excess accumulation of lipid droplets in various peripheral cell types such as hypertrophic adipocytes and fatty hepatocytes [3, 33, 34] . The lipid-laden cells not only cause metabolic derangement, but also inflammation accompanied by activation of NF-jB pathway, and such cells are closely associated with obesity, fatty liver, atherosclerosis [3, 33, 34] . Astrocytes easily detect peripheral signals because of their physical proximity to blood vessels, and hence play an important role in transporting/storing nutrients. Moreover, peripherally administered fatty acids primarily accumulate in astrocytes [35, 36] . Notably, we found that prolonged treatment of astrocytes with FFA resulted in enhanced accumulation of lipid droplets in the cells (C8-D1A astrocytic cell line, primary astrocytes from whole brain and/or hypothalamus). Since astrocytes play a major role in hypothalamic sensing and handling of circulating nutrients, the lipid droplet formation in astrocytes may be essential to protect the neighboring neuron from the toxic mediator FFA influx into the hypothalamus under HFD-feeding/obese conditions. In this in vitro study, we for the first time demonstrated that lipid-laden astrocytes produce large amounts of inflammatory mediators (TNFa, IL-1b, IL-6, MCP-1), strongly suggesting that the increased inflammatory reactivity of lipid-laden astrocytes, which accumulate lipid droplets under FFA-rich condition, may participate in the onset of hypothalamic inflammation. It should be noted that astrocytes can interact with neighboring cells by releasing various mediators, including cytokines/chemokines [37, 38] . Hence, we thought that lipid-laden fatty astrocytes-derived inflammatory chemokines such as MCP-1 may affect neighboring glial cells such as microglia in the hypothalamus. To test this, we treated microglia with LL-As-CM or control (C-As-CM). We found that LL-As-CM markedly enhanced the chemotactic activity of microglia migration, and upregulated its receptor CCR2 in the cells. Moreover, the chemotactic activity of LL-As-CM was blunted by treatment with anti-MCP-1, indicating that the lipid-laden astrocytesderived MCP-1 causes microglia migration through the MCP-1 receptor CCR2. Notably, LL-As-CM markedly enhanced microglia activation accompanied by activation markers (Iba-1 and CD11b) and upregulated inflammatory mediators (TNFa, IL-6, MCP-1) in the cells. Recent studies have shown that prolonged HFD-feeding increases the number of microglia in the hypothalamus, which has been attributed to increased infiltration of bone marrow-derived monocytes/macrophages into the central nervous system and hypothalamus [12, [39] [40] [41] [42] . Moreover, it is likely that chemokine MCP-1 is able to disrupt the integrity of BBB [43] . In this respect, astrocytes-derived chemokines such as MCP-1 may act as recruiting signals for peripheral macrophages by enhancing BBB permeability. Taken together, these findings suggest that the lipid-laden fatty astrocytes-derived inflammatory cytokines may increase their inflammatory cross-talk with the neighboring microglia, augmenting the hypothalamic inflammatory responses.
In conclusion, we demonstrated that H-astrocytes can be activated by obese adipose tissue-derived mediators, and they accumulate lipid droplets under FFA-rich environments in vitro. The lipid-laden astrocytes-derived cytokines/chemokines increased chemotactic activity of microglia and activated the cells to produce inflammatory mediators. These findings suggest that the crosstalk between lipid-laden astrocytes and microglia through inflammatory mediators may be crucial for obesityinduced hypothalamic inflammation.
